<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[184, 187] platelet response.<br>[191, 194] response to treatment<br>[227, 230] odds of response<br>[303, 304] responded<br>[327, 330] odds of responding<br>[374, 376] concomitant treatment<br>[398, 400] rescue treatment<br>[423, 425] thromboembolic events<br>[456, 460] alanine aminotransferase concentration,<br>[480, 483] total bilirubin.<br>[492, 496] serious bleeding events,<br></td>
<td width=33%>
[40, 41] response<br>[184, 187] platelet response.<br>[191, 194] response to treatment<br>[227, 230] odds of response<br>[303, 306] responded to treatment<br>[327, 330] odds of responding<br>[374, 376] concomitant treatment<br>[398, 400] rescue treatment<br>[423, 425] thromboembolic events<br>[456, 460] alanine aminotransferase concentration,<br>[480, 483] total bilirubin.<br>[492, 496] serious bleeding events,<br>[513, 514] effective<br></td>
<td width=33%>
[40, 41] response<br>[91, 93] platelet counts<br>[143, 145] platelet count<br>[184, 187] platelet response.<br>[191, 201] response to treatment (defined as a platelet count of<br>[226, 230] the odds of response<br>[303, 306] responded to treatment<br>[327, 330] odds of responding<br>[373, 376] reduced concomitant treatment<br>[397, 400] needed rescue treatment<br>[423, 425] thromboembolic events<br>[453, 460] mild increases in alanine aminotransferase concentration,<br>[478, 483] increases in total bilirubin.<br>[492, 496] serious bleeding events,<br>[513, 521] effective for management of chronic immune thrombocytopenia,<br></td>
</tr>
